Danaparoid (Orgaran)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 20:33, 10 December 2018 by Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism: Low molecular weight heparin ==History of changes in FDA indication== *6/26/2001: Initial FDA approval ==Also known as== *'''Brand n...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

General information

Class/mechanism: Low molecular weight heparin

History of changes in FDA indication

  • 6/26/2001: Initial FDA approval

Also known as

  • Brand name: Orgaran
Retrieved from "https://hemonc.org/w/index.php?title=Danaparoid_(Orgaran)&oldid=33300"